Cell最新的影响因子从去年的64.5降到了45.5，跌幅达29.4%；而Cell Research从去年的44.1降到了28....
而在「Rational engineering of minimally immunogenic nucleases for gene therapy」研究中,团队通过 MHC 相关肽蛋白质组学分析,成功鉴定出 SaCas9 和 AsCas12a 的潜在免疫原性表位,并设计出可有效逃避免疫检测的变体,显著降低了免疫原性,为...
2024 年 12 月 17 日,来自美国希望之城国家医疗中心贝克曼研究所的 RNA 研究与治疗中心主任、系统生物学系主任陈建军教授,邓晓岚研究副教授与陈振华博士共同在Cell发表题目为「YTHDF2 promotes ATP synthesis and immune evasion in B-c...
据不完全统计,2024年,1000+篇合作文章在国际顶尖舞台上绽放光彩,累计影响因子9000+。其中,CNS 9篇、Cell Metab 11篇、Nat Metab 4篇、Nat Cell Bio 3篇、Mol Cell 5篇,影响因子10分以上合作文章214篇。这学术成果的发表,既见证了无数研究人员在科研探索路上的重大突破,也是对景杰生物产品与服务品质的认可。
Visualizing Engrafted Human Cancer and Therapy Response in Immunodeficient Zebrafish 作者:C Yan,DC Brunson,Q Tang,D Do,NA Iftimia,JC Moore,MN Hayes,AM Welker,EG Garcia,TD Dubash 通讯单位:美国麻省总医院 杂志:Cell 影响因子:64.5/Q2 翻译:韩成 ...
影响因子(2023) 29.268Cell Press is a leading publisher of cutting-edge biomedical research and reviews. We drive science forward and promote cross-pollination of ideas with our passion for excellence and commitment to innovation. Our aim is to engage the scientific community by communicating important...
An enhancer-based gene-therapy strategy for spatiotemporal control of cargoes during tissue repair 5.从收到稿件到接受稿件用时:8.6个月 Organoid modeling of human fetal lung alveolar development reveals mechanisms of cell fate patterning and neonatal respiratory disease ...
论文题目:《N1-Methyladenosine Formation, Gene Regulation, Biological Functions, and Clinical Relevance》 杂志名称:Cell子刊:《Molecular Therapy》 中科院分区及影响因子:中科院1区;IF=12.91 通讯作者: 姓名:石蓓 科室:心血管内科 职称:主任医师,二级教授 ...
Hadassah University Medical Center Sidney and Judy Swartz Embryonic Stem Cell Research Center of The Goldyne Savad Institute of Gene Therapy and The Department of Obstetrics and Gynecology, Jerusalem, Israel Human Embryonic Stem Cells, Regeneration, Cell therapy Professor Mara Riminucci, MD, PhD...
兼任亚大免疫学会联盟秘书长(2012-2015担任主席),创办《中国肿瘤生物治疗杂志》并任主编,Cellular and Molecular Immunology共同主编、任Journal of Molecular Medicine、Gene Therapy、Cancer Immunology Research副主编, 任Cell、Annual Review of Immunology、Science Translational Medicine、Science Advances、eLife、Cell ...